Neal Maru, MD
Neurology · Alexandria, VANPI 1881890648
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,851 and has fallen 88.4% since, to $215 in 2025.
Across 194 payments — averaging $21.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$559
- Teva Pharmaceuticals USA, Inc.$389
- Supernus Pharmaceuticals, Inc.$338
- Jazz Pharmaceuticals Inc.$332
- Novartis$300
- Amgen$284
- plus $2K from 28 others
What the payments were for
- Speaking & faculty fees$952%
- Food & beverage$3,91195%
- Education$1283%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 19 | $559 |
| Teva Pharmaceuticals USA, Inc. | 13 | $389 |
| Supernus Pharmaceuticals, Inc. | 19 | $338 |
| Jazz Pharmaceuticals Inc. | 14 | $332 |
| Novartis | 17 | $300 |
| Amgen | 9 | $284 |
| Avanir Pharmaceuticals, Inc. | 13 | $198 |
| Lilly USA, LLC | 10 | $170 |
| AbbVie | 13 | $158 |
| UCB, Inc. | 9 | $149 |
| Axsome Therapeutics, Inc. | 6 | $132 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $123 |
| Acorda Therapeutics, Inc | 5 | $95 |
| Inspire Medical Systems, Inc. | 3 | $91 |
| ZOLL Respicardia, Inc. | 4 | $86 |
| Arbor Pharmaceuticals, Inc. | 5 | $84 |
| Neurocrine Biosciences, Inc. | 4 | $81 |
| Biogen | 1 | $76 |
| Sanofi | 3 | $64 |
| Merz North America, Inc. | 1 | $53 |
| Kyowa Kirin, Inc. | 2 | $41 |
| Assertio Therapeutics, Inc. | 2 | $41 |
| Lundbeck LLC | 2 | $41 |
| Upsher-smith Laboratories LLC | 2 | $39 |
| MDD US Operations, LLC | 2 | $32 |
| Resmed Corp | 1 | $28 |
| Sunovion Pharmaceuticals Inc. | 2 | $27 |
| Amneal Pharmaceuticals LLC | 1 | $24 |
| Strongbridge US Inc. | 1 | $22 |
| Neurelis, Inc. | 1 | $19 |
| Itamar Medical Inc | 1 | $17 |
| Promius Pharma LLC | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,134 in reported general payments places this provider in the 65th percentile of 474 neurology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelsomraSuvorexant | 17 | $10,046 |
| Gabapentin | 51 | $394 |
| Eszopiclone | 30 | $350 |
| Clonazepam | 19 | $19 |
Paid to pharmacies, not to this prescriber.
Other neurology in Alexandria
- Ramsey FalconerAlexandria$2M
- Simon FishmanAlexandria$207K
- Mohankumar KurukumbiAlexandria$64K
- John CochranAlexandria$54K
- Eric SklarAlexandria$52K
- Sean RogersAlexandria$28K
- Robert ShinCharlottesville$1.7M
- Heidi CraytonVienna$1.5M
- Mark LandrioWinchester$631K
- Catherine HamRichmond$603K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.